Axsome Therapeutics (AXSM) Cash & Equivalents Growth (5y) (2020 - 2026)
Axsome Therapeutics (AXSM) Cash & Equivalents Growth (5y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Axsome Therapeutics |
12.84 Bn |
12.54 Bn |
176.48 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
13.13% |
| Dec 31, 2025 |
11.92% |
| Sep 30, 2025 |
9.96% |
| Jun 30, 2025 |
9.71% |
| Mar 31, 2025 |
8.81% |
| Dec 31, 2024 |
7.47% |
| Sep 30, 2024 |
49.63% |
| Jun 30, 2024 |
42.48% |
| Mar 31, 2024 |
50.71% |
| Dec 31, 2023 |
94.24% |
| Sep 30, 2023 |
93.85% |
| Jun 30, 2023 |
84.67% |
| Mar 31, 2023 |
56.06% |
| Dec 31, 2022 |
42.63% |
| Sep 30, 2022 |
48.34% |
| Jun 30, 2022 |
14.07% |
| Mar 31, 2022 |
13.47% |
| Dec 31, 2021 |
18.75% |
| Sep 30, 2021 |
27.59% |
| Jun 30, 2021 |
29.52% |
